Congenital Heart Defects in Children | NYU Langone Health
Cardiac specialist at Hassenfeld Children’s Hospital at NYU Langone diagnose and treat babies and children with congenital heart disease.
NYU Langone Cardiology Associates—Atlantis/Lake Worth | NYU Langone Health
Doctors at NYU Langone Cardiology Associates—Atlantis/Lake Worth offer high-quality care for conditions affecting the heart.
Ronald O. Perelman Center for Emergency Services | NYU Langone Health
NYU Langone’s Ronald O. Perelman Center for Emergency Services offers emergency care for illness and injuries.
Recovery & Support for Children with Urinary Tract Infections | NYU Langone Health
Experts at Hassenfeld Children’s Hospital at NYU Langone offer support for children during and after treatment for a urinary tract infection.
Your Visit to Stephen D. Hassenfeld Children's Center for Cancer & Blood Disorders | NYU Langone Health
Get information on what to expect from your first visit to NYU Langone’s Stephen D. Hassenfeld Children’s Center for Cancer and Blood Disorders.
Randomized Controlled Open-Label Parallel Group Multi-Center Prospective Phase 4 Study Comparing the Efficacy of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2 3 and 4 Pressure Injuries
This post-marketing study is being performed to assess the effectiveness of Altrazeal® Transforming Powder Dressing (“Altrazeal®” or “TPD”) manufactured by ULURU Inc. in patients with pressure injuries (sometimes also referred to as pressure sores or decubitus ulcers) compared to the current Standard of Care (SOC) therapies. TPD is manufactured, marketed, and used in the United States of America (US). ULURU Inc. is registered with the US Food and Drug Administration (FDA) and Altrazeal® is listed as a Class I 510(k) exempt medical device: “dressing, wound, hydrogel without drug and/or biologic.” (https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?lid=410757&lpcd=NAE) Under the supervision of a health care professional, TPD may be used in surgical, acute or chronic wounds including pressure injuries.Objectives:Primary: To compare the efficacy of TPD in reducing primary dressing changes in the treatment of non-infected Stage 2, 3 and 4 pressure injuries (PrIs).Secondary: Evaluate: 1) wound healing trajectories2) safety in the form of adverse events3) subject pain for sensate patientsExploratory: Evaluate: 1) resource utilization of TPD relative to SOC2) cost-effectiveness of TPD versus SOC3) budget impact analysis of adopting TPD4) wound quality of life5) research subject satisfaction6) other ad-hoc analyses as warranted
Trabecular Structure on Wrist MRI in Early Osteoporosis
Osteoporosis and its complications - specifically, fragility fractures - constitute an enormous medical, economical, and societal burden. This problem is best addressed by prevention, but an optimal screening tool for osteoporotic fractures is still lacking. MRI of the hips and wrist has been shown in multiple studies to be sensitive and specific for the diagnosis of osteoporosis. Furthermore, this modality does not require radiation exposure making it an attractive option for screening. However the ability of MRI to predict fractures remains unclear. Using wrist MRI evaluation of trabecular structure may allow for early detection of osteoporotic changes enabling effective preventive treatment. Since, wrist changes have been shown to occur earlier in the course of osteoporosis, wrist MRI may be better suited for screening. This pilot study aims to establish preliminary data for the use of MRI of the distal radius to predict osteoporotic fractures early in the course of the condition. Wrist MRIs of subjects at high-risk for osteoporotic fracture (subjects with a history of a fragility fracture) will be compared to wrist MRIs of age matched subjects that are at low risk. MRI measures compared will include quantitative assessment of trabecular bone thickness and the amount of bone porosity. The results of this pilot study will serve as a basis for further study by refining the testing protocol and defining the sample size enabling large-scale longitudinal assessment of this novel diagnostic tool
Recovery & Support for Migraine | NYU Langone Health
NYU Langone specialists closely monitor your medical treatment and offer supportive care to help alleviate migraine pain.
Ambulatory Care Expansion | NYU Langone Health
NYU Langone’s reach is increasingly extending further into the surrounding neighborhood and region.
Liver Cancer & Liver Metastases | NYU Langone Health
Experts at NYU Langone’s Perlmutter Cancer Center diagnose and treat people who have liver cancer and liver metastases.